PackGene received B+ round of financing led by Sequoia China and co-invested by Decheng Capital

In October 2020,, Guangzhou PackGene Biotechnology Co., Ltd. (PackGene), an integrated solution provider focusing on AAV vector packaging and gene therapy CDMO, announced the completion of a new round of B+ round of financing, which was led by Sequoia China, followed by Decheng Capital. Cathay Capital and Oriza Seed also continued to participate in the investment. This round of financing will be another strategic cooperation between PackGene and investment partners with a global vision and a wide-ranging deployment in the biological industry.